Jazz is an industry leader in treating sleep disorders and epilepsy, and in oncology it is investigating and delivering medicines for hard-to-treat hematologic malignancies and solid tumors. Within these therapeutic areas, the company is identifying new options for patients by actively exploring small molecules and biologics, and through innovative delivery technologies and cannabinoid science.